Access Biotechnology has 3 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. It is a growth equity firm based in New York City, US, founded in 1986. Its most recent investment on record is Matchpoint Therapeutics's $150M Series B+ round in October 2026, alongside T1D Fund, Sanofi Ventures, Norwest Venture Partners and 6 others. By category, its portfolio leans toward Health and bio (3) and Education (1). It has co-invested with Nextech Invest, Atlas Venture and Norwest Venture Partners, most often Nextech Invest (2 rounds).

About Access Biotechnology

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

What Access Biotechnology invests in

• Health and bio · 3 · 100%
• Education · 1 · 33%

Access Biotechnology recent investments

Company	Round	Date	Alongside
MMatchpoint Therapeutics	Series B+ · $150M	Oct 7, 2026	T1D Fund, Sanofi Ventures, Norwest Venture Partners (lead) +6
MMariana Oncology	Series B+ · $175M	Sep 7, 2023	Surveyor Capital, RA Capital Management, Nextech Invest +4
DDisc Medicine	Series A · $50M	Oct 1, 2019	Novo Holdings (lead), Foresite Capital, Atlas Venture

How Access Biotechnology invests

Share is of the 3 rounds on Recent Funding that name Access Biotechnology. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Access Biotechnology portfolio companies

• MMatchpoint Therapeutics$150MSeries B+ · Oct 2026
• MMariana Oncology$175MSeries B+ · Sep 2023
• DDisc Medicine$50MSeries A · Oct 2019

Most frequent co-investors

• NNextech Invest2 shared rounds · last Oct 7, 2026
• AAtlas Venture2 shared rounds · last Oct 7, 2026
• NNorwest Venture Partners1 shared round · last Oct 7, 2026
• SSanofi Ventures1 shared round · last Oct 7, 2026
• IInvus1 shared round · last Oct 7, 2026
• DDigitalis Ventures1 shared round · last Oct 7, 2026
• TT1D Fund1 shared round · last Oct 7, 2026
• BBOLD Longevity Growth Fund1 shared round · last Oct 7, 2026
• BBB Biotech1 shared round · last Oct 7, 2026
• DDeep Track Capital1 shared round · last Sep 7, 2023
• EEli Lilly1 shared round · last Sep 7, 2023
• RRA Capital Management1 shared round · last Sep 7, 2023

Similar investors

• PPositive Sum3 companies · 4 deals in 12 mo
• IInnovestor3 companies · 3 deals in 12 mo
• FFrazier Life Sciences3 companies · 2 deals in 12 mo
• GGoHub Ventures3 companies · 2 deals in 12 mo
• HHealthier Capital3 companies · 2 deals in 12 mo
• KKadmos Capital3 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Access Biotechnology, which is a subset of its real portfolio. API: /api/v1/investors/access-biotechnology (get a free API key). More: the most active VC firms and new venture capital funds.